FDA clears Moderna COVID-19 vaccine for emergency use

Main entrance to Building 1 at the FDA’s White Oak campus

The Food and Drug Administration authorized Moderna’s COVID-19 vaccine on Friday for emergency use in adults 18 and older. The decision gives the United States a second vaccine as health workers begin administering the Pfizer-BioNTech shots authorized last week.

Moderna developed the vaccine with scientists from the National Institutes of Health. It uses messenger RNA to instruct cells to make a piece of the coronavirus that the immune system can learn to recognize. The two doses are given one month apart.

The FDA said it will continue monitoring the vaccine’s safety as it reaches more people. The agency said the available data do not yet establish how long protection lasts or whether vaccination prevents transmission.

Reporting source. Cover photograph: U.S. Food and Drug Administration, public domain.